CVS raises annual profit forecast on improved drug revenues
CVS Health raised its 2026 adjusted profit per share forecast to $7.90-$8.10 from $7.30-$7.50, citing strong pharmacy drug revenues and government health plan bonus payments.
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Eli Lilly topped second-quarter earnings and revenue estimates while raising its full-year guidance, driven by strong sales of its weight-loss drug Zepbound and diabetes treatment Mounjaro.
Tariff refund drives Q2 profit at Delta Galil
Delta Galil’s second-quarter sales rose 9% to $511.6m, with net income increasing to $34.4m, boosted by tariff refunds and strong operational performance.
Fintech broker Clear Street offers investors pre-IPO access to $188 billion AI giant Databricks
Clear Street, a fintech prime brokerage, is launching a platform enabling accredited investors to purchase interests in private companies before their public debuts, beginning with AI software firm Databricks valued at $188 billion.
Thai Union ups forecasts after “strong” Q2
Thai Union raised its full-year sales forecast to 4-6% growth from 3-4% previously, citing strong second-quarter results with record gross margins and expanding volumes across key segments.
Loews Reports Higher Second-Quarter Profit as Revenue Continues to Grow
Loews Corporation reported second-quarter net income of $444 million, up from $391 million a year earlier, as its insurance, pipeline and hospitality divisions all posted improved results.